By Amy Siegel, S2N Health
The Business of Emerging Medtech
Emerging medtech margins: Don’t think price, think COGS
By Tim Kofol, S2N Health
Marketing steps up in med tech
By Amy Siegel & Tim Kofol, S2N Health
It’s not so Symple: the Rise (and Fall?) of Renal Denervation
5 New Year’s resolutions for medtech companies
By Amy Siegel, S2N Health
As I sit here reaching for one more stale holiday cookie, mulling the merits of spiked eggnog vs. spiked hot cider, I realize it’s time to make some New Year’s resolutions. Ugh. I much prefer hiding under the covers in blissful denial, but activation is required before the situation turns dire. Similarly, the medical device industry, still a bit complacent and bloated from the good old days, needs to confront the new reality of the lean, mean healthcare marketplace and take action.
Making the Most of Scientific Meetings – 5 Tips for Emerging Medtech Companies
Medical Device Startups: 5 essentials for your pitch deck
By Amy Siegel, S2N Health
Last month I had the sadistic pleasure of serving as a judge for a business plan competition at the 2013 AdvaMed conference. I have to give credit to the fledgling entrepreneurs who agree to present at such sessions, designed to publicly expose the flaws of their technology, commercial story and personal presentation styles. The only grimmer form of torture is watching a videotape of yourself giving the company pitch.
The Asthmatx story: Reimbursement fundamentals for disruptive medical technologies
By Amy Siegel, S2N Health
Many new medical technologies, particularly the low- or mid-tech ones, fit more or less neatly into an existing reimbursement code. For the companies developing such devices, de-risking involves demonstrating 1) it works and won’t kill anyone, 2) the path through FDA is efficient, 3) the company can manufacture it at attractive margins, and 4) enough people will want to buy to imagine profitability.
Should I fund my medical device company on Kickstarter?
By Tim Kofol, S2N Health
Emerging markets: MedTech heads to Africa
By Erin Warner
The large medtech companies talk endlessly about emerging markets delivering their top-line growth targets, and they are not just talking about BRIC countries anymore.
Medical Devices: What does it really mean to be disruptive?
By Amy Siegel & Tim Kofol, S2N Health
In our line of work, we come across many innovative medical technologies appended with the adjective “disruptive” but some uses of the term require more squinting to imagine than others.
The disruptive label is enticing because big ideas are associated with big funding and big exits in the emerging medtech landscape. Alas, there is no objective measure of a device’s potential disruptiveness; like pornography, to paraphrase a former Supreme Court justice, “you know it when you see it.”